Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 568-578 , June 2005

A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life

  • Matthew L. Maciejewski

      Affiliations

    • Northwest Center for Outcomes Research in Older Adults, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA, USA
    • Department of Health Services, University of Washington, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. Tel.: 206-764-2445; fax: 206-764-2935.
    • ,
  • Donald L. Patrick

      Affiliations

    • Department of Health Services, University of Washington, Seattle, WA, USA
    • Department of Epidemiology, University of Washington, Seattle WA, USA
    • ,
  • David F. Williamson

      Affiliations

    • Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA

,Accepted 25 October 2004.

References 

  1. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22:39–47
  2. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522
  3. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–1200
  4. National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. NIH Publication No. 98-4083. September 1998. Bethesda, MD: NIH; 1998.
  5. Pirozzo S, Summerbell C, Cameron C, Glasziou P. Advice on low-fat diets for obesity. Cochrane Database Syst Rev. 2002;(2):CD003640
  6. Colquitt J, Clegg A, Sidhu M, Royle P. Surgery for morbid obesity. Cochrane Database Syst Rev. 2003;(2):CD003641
  7. Padwal R, Li S, Lau D. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2003;(4):CD004094
  8. U.S. Preventive Services Task Force . Screening for obesity in adults: recommendations and rationale. Ann Intern Med. 2003;139:930–932
  9. Sullivan MBE, Sullivan LGM, Kral JG. Quality of life assessment in obesity: physical, psychological, and social function. Gastroenterol Clin North Am. 1987;16:433–442
  10. Patrick DL. Patient-reported outcomes (PROs): an organizing tool for concepts, measures, and applications. MAPI Quality of Life Newsl. 2003;31:1–5Available from http://www.mapi-research.fr/pdf/newsletter/qol31.pdf
  11. Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. New York: Oxford University Press; 1993;
  12. Kushner RF, Foster GD. Obesity and quality of life. Nutrition. 2000;16:947–952
  13. Fontaine KR, Barofsky I. Obesity and health-related quality of life. Obes Rev. 2001;2:173–182
  14. Nieman DC, Custer WF, Butterworth DE, Utter AC, Henson DA. Psychological response to exercise training and/or energy restriction in obese women. J Psychosom Res. 2000;48:23–29
  15. Bacon L, Keim NL, Van Loan MD, Derricote M, Gale B, Kazaks A, et al. Evaluating a ‘non-diet’ wellness intervention for improvement of metabolic fitness, psychological well-being and eating and activity behaviors. Int J Obes Relat Metab Disord. 2000;26:854–865
  16. Chow CC, Ko GT, Tsang LW, Yeung VT, Chan JC, Cockram CS. Dexfenfluramine in obese Chinese NIDDM patients: a placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors. Diabetes Care. 1997;20:1122–1127
  17. Clifford PA, Tan SY, Gorsuch RL. Efficacy of a self-directed behavioral health change program: weight, body composition, cardiovascular fitness, blood pressure, health risk, and psychosocial mediating variables. J Behav Med. 1991;14:303–323
  18. Randomised trial of jejunoileal bypass versus medical treatment in morbid obesity. The Danish Obesity Project. Lancet. 1979;2(8155):1255–1258
  19. Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, et al. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2000;2:175–187
  20. Goodrick GK, Pendleton VR, Kimball KT, Carlos Poston WS, Reeves RS, Foreyt JP. Binge eating severity, self-concept, dieting self-efficacy and social support during treatment of binge eating disorder. Int J Eat Disord. 1999;26:295–300
  21. Grimm RH, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med. 1997;157:638–648
  22. Hawke A, O'Brien P, Watts JM, Hall J, Dunstan RE, Walsh JF, et al. Psychosocial and physical activity changes after gastric restrictive procedures for morbid obesity. Aust N Z J Surg. 1990;60:755–758
  23. Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA. 2003;289:1792–1798
  24. James WP, Avenell A, Broom J, Whitehead J. A one-year trial to assess the value of orlistat in the management of obesity. Int J Obes Relat Metab Disord. 1997;21(Suppl 3):S24–S30
  25. Karlsson J, Sjostrom L, Sullivan M. Swedish Obese Subjects (SOS)—an intervention study of obesity: two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord. 1998;22:113–126
  26. Kaukua J, Pekkarinen T, Sane T, Mustajoki P. Health-related quality of life in WHO Class II–III obese men losing weight with a very-low-energy diet and behavior modification: a randomised clinical trial. Int J Obes Relat Metab Disord. 2002;26:487–495
  27. Kiernan M, King AC, Stefanick ML, Killen JD. Men gain additional psychological benefits by adding exercise to a weight-loss program. Obes Res. 2001;9:770–777
  28. Laederach-Hofmann K, Graf C, Horber F, Lippuner K, Lederer S, Michel R, et al. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. Int J Eat Disord. 1999;26:231–244
  29. MacLachlan M, Connacher AA, Jung RT. Psychological aspects of dietary weight loss and medication with the atypical beta agonist BRL 26830A in obese subjects. Int J Obes. 1991;15:27–35
  30. Mazzoni R, Mannucci E, Rizzello SM, Ricca V, Rotella CM. Failure of acupuncture in the treatment of obesity: a pilot study. Eat Weight Disord. 1999;4:198–202
  31. McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2000;160:2185–2191
  32. Messier SP, Loeser RF, Mitchell MN, Valle G, Morgan TP, Rejeski WJ, et al. Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study. J Am Geriatr Soc. 2000;48:1062–1072
  33. Metz JA, Stern JS, Kris-Etherton P, Reusser ME, Morris CD, Hatton DC, et al. A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction. Arch Intern Med. 2000;160:2150–2158
  34. Nguyen NT, Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life and costs. Ann Surg. 2001;234:279–289discussion 289–91
  35. O'Loughlin J, Paradis G, Meshefedjian G, Kishchuk N. Evaluation of an 8-week mailed healthy-weight intervention. Prev Med. 1998;27:288–295
  36. Painot D, Jotterand S, Kammer A, Fossati M, Golay A. Simultaneous nutritional cognitive–behavioral therapy in obese patients. Patient Educ Couns. 2001;42:47–52
  37. Ramirez EM, Rosen JC. A comparison of weight control and weight control plus body image therapy for obese men and women. J Consult Clin Psychol. 2001;69:440–446
  38. Rapoport L, Clark M, Wardle J. Evaluation of a modified cognitive-behavioural programme for weight management. Int J Obes Relat Metab Disord. 2000;24:1726–1737
  39. Rejeski WJ, Focht BC, Messier SP, Morgan T, Pahor M, Penninx B. Obese, older adults with knee osteoarthritis: weight loss, exercise, and quality of life. Health Psychol. 2002;21:419–426
  40. Renjilian DA, Perri MG, Nezu AM, McKelvey WF, Shermer RL, Anton SD. Individual versus group therapy for obesity: effects of matching participants to their treatment preferences. J Consult Clin Psychol. 2001;69:717–721
  41. Rippe JM, Price JM, Hess SA, Kline G, DeMers KA, Damitz S, et al. Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. Obes Res. 1998;6:208–218
  42. Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G, European Orlistat Obesity Study Group . Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res. 2000;8:49–61
  43. Shah M, McGovern P, French S, Baxter J. Comparison of a low-fat, ad libitum complex-carbohydrate diet with a low-energy diet in moderately obese women. Am J Clin Nutr. 1994;59:980–984
  44. Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ. 2000;320:827–832[Erratum in: BMJ 2000;320:984]
  45. Tanco S, Linden W, Earle T. Well-being and morbid obesity in women: a controlled therapy evaluation. Int J Eat Disord. 1998;23:325–339
  46. Wardle J, Rogers P, Judd P, Taylor MA, Rapoport L, Green M, et al. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am J Med. 2000;108:547–553
  47. Williams PG, Surwit RS, Babyak MA, McCaskill CC. Personality predictors of mood related to dieting. J Consult Clin Psychol. 1998;66:994–1004
  48. Briss PA, Zaza S, Pappaioanou M, Fielding J, Wright-De Aguero L, Truman BI, et al. The Task Force on Community Preventive Services. Developing an evidence-based Guide to Community Preventive Services: methods. Am J Prev Med. 2000;18(Suppl 1):S35–S43
  49. Zaza S, Wright-De Aguero LK, Briss PA, Truman BI, Hopkins DP, Hennessy MH, et al. Task Force on Community Preventive Services. Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Am J Prev Med. 2000;18(Suppl 1):S44–S74
  50. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed.. New York: McGraw-Hill; 1994;
  51. Rosnow RL, Rosenthal R. Computing contrasts, effect sizes, and counternulls on other people's published data: general procedures for research consumers. Psychol Methods. 1996;1:331–340
  52. Dunlop WP, Cortina JM, Vaslow JB, Burke MJ. Meta-analysis of experiments with matched groups or repeated measures designs. Psychol Methods. 1996;1:170–177
  53. Normand SLT. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18:321–359
  54. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289:1537–1545
  55. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  56. Alderson P, Green S, Higgins JPT, editors. Chapter 6: assessment of study quality. In: Cochrane reviewers' handbook 4.2.2 [Internet]. Updated Dec, 2003. Available from: www.cochrane.dk/cochrane/handbook/hbook.htm.
  57. Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res. 1996;5:496–502
  58. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N, European Regulatory Issues on Quality of Life Assessment Group . Patient-reported outcomes: the example of health-related qualify of life—a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J. 2002;36:209–238
  59. Symonds T, Berzon R, Marquis P, Rummans TA, Clinical Significance Consensus Meeting Group . The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clin Proc. 2002;77:572–583
  60. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  61. Levine MN, Ganz PA. Beyond the development of quality-of-life instruments: where do we go from here?. J Clin Oncol. 2002;20:2215–2216
  62. Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW. Is obesity associated with major depression? Results from the third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003;158:1139–1147
  63. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(Suppl 3):S217–S232
  64. Guyatt GH, Jaeshke R, Feeny DH, Patrick DL. Measurements in clinical trials: choosing the right approach. In:  Spilker B editors. Quality of life and pharmacoeconomics in clinical trials. 2nd ed.. Hyattsville, MD: Lippincott-Raven; 1996;p. 41–48
  65. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59:877–883
  66. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping and proxy risk factors. Am J Psychiatry. 2001;158:848–856

PII: S0895-4356(04)00322-1

doi: 10.1016/j.jclinepi.2004.10.015

Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 568-578 , June 2005

Article Tools

* Image Usage & Resolution